Section 7. Clinical Considerations
(increase to a higher grade per the DAIDS toxicity table) or frequency during follow-up, are considered AEs. Chronic conditions should be documented as ‘ongoing’ at enrollment (“Is the condition ongoing?” should be selected as “Yes”), even if the participant is not currently experiencing an acute event (e.g. intermittent headaches).
Download Section 7. Clinical Considerations
Information
Domain:
Source:
Link to this page:
Related documents
Effective Date: 09/28/19 Document No.: MAN-A-OD-001
www.niaid.nih.govDAIDS Guidelines for Good Clinical Laboratory Practice Standards The development of these GCLP standards was a collaborative effort between PPD and the Division of AIDS (DAIDS). The authors that have contributed to this document are listed below: PPD, Inc.: DAIDS: Global Government andPublic Health Services, Laboratory DAIDS Clinical Laboratory
Grading Adverse Events - DAIDS Regulatory Support Center …
rsc.niaid.nih.govDivision of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 2. 1 consists of parameters, or AEs, with severity grading guidance that are to be used in DAIDS clinical trials for safety data reporting to maintain accuracy and consistency in the evaluation of AEs.